PMID: 8590786Oct 1, 1995Paper

Decreased capacity to inhibit platelet hyperactivity and to stabilize prostacyclin of high-density lipoproteins in experimental diabetes

Acta Diabetologica
I GinonM Ciavatti

Abstract

Twenty-eight male Sprague Dawley rats were divided into two groups: a control group (C) of 15 animals and a streptozotocin-induced diabetes group mildly balanced by insulin (D) of 13 animals. After 15 weeks, plasma and high-density lipoprotein (HDL) lipids were determined in each group. Apoprotein A-I concentration was evaluated in HDL fractions. The capacity of the HDL fraction to inhibit thrombin and ADP-induced aggregation of normal platelets was determined for each rat, and in an additional experiment the relation dose-effect of HDL was established. The effect of HDL of the two groups on the stabilization of prostacyclin was compared by aggregation bioassay. After 15 weeks, HDL cholesterol (free + esterified). After 15 weeks, HDL cholesterol (free + esterified) tended to increase in group D compared with group C (P < 0.08). By contrast, apoprotein A-I was very significantly decreased in HDL-D compared with HDL-C (P < 0.001). These alterations were accompanied by a significantly decreased capacity of HDL (60 micrograms/ml platelet suspension) to inhibit ADP-induced aggregation (P< 0.0001) in group D compared with group C. Furthermore, HDL-D incubated 45 or 90 min with prostacyclin showed a significantly decreased capacity to...Continue Reading

References

Mar 1, 1976·The Journal of Clinical Investigation·H Bar-OnH A Eder
Mar 1, 1975·The Journal of Clinical Investigation·S J ShattilR A Cooper
Jun 1, 1975·Annals of Internal Medicine·J SagelM Laimins
Aug 1, 1990·The Journal of Clinical Investigation·A R Tall
May 22, 1990·Biochimica Et Biophysica Acta·S ParthasarathyL G Fong
Feb 1, 1988·The American Journal of Clinical Nutrition·C ColetteE Cartry
Nov 1, 1984·Analytical Biochemistry·F Omodeo SalèB Berra
Mar 1, 1983·Atherosclerosis·M Aviram, J G Brook
Jul 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D G HassallB Lewis

❮ Previous
Next ❯

Citations

Jul 27, 2001·Diabetes Care·A I VinikG L Pittenger

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.